Home Stock

Stock Research: OPKO Health

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

OPKO Health

NSQ:OPK US68375N1037
29
  • Value
    76
  • Growth
    5
  • Safety
    Safety
    63
  • Combined
    42
  • Sentiment
    33
  • 360° View
    360° View
    29
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. It operates in pharmaceutical and diagnostics industries, with key pharmaceutical products like Somatrogon (NGENLA) and Rayaldee, and clinical laboratory operations through BioReference. Its pharmaceutical operations are in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, and the United States. In the last fiscal year, the company had a market cap of $1071 millions, profits of $219 millions, revenue of $713 millions, and 2997 employees.

more

ANALYSIS: With an Obermatt 360° View of 29 (better than 29% compared with alternatives), overall professional sentiment and financial characteristics for the stock OPKO Health are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for OPKO Health. The consolidated Value Rank has an attractive rank of 76, which means that the share price of OPKO Health is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 76% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 63. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 33. Professional investors are more confident in 67% other stocks. The consolidated Growth Rank also has a low rank of 5, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 95 of its competitors have better growth. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Market Pulse
Country USA
Industry Health Care Services
Size Medium
Website opko.com
Index
NASDAQ
OPKO Health stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
76 41 44 18
Growth
5 57 67 1
Safety
Safety
63 86 49 61
Sentiment
33 49 42 13
360° View
360° View
29 77 38 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
31 95 95 95
Opinions Change
50 50 50 50
Pro Holdings
n/a 51 44 3
Market Pulse
98 10 7 4
Sentiment
33 49 42 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
76 41 44 18
Growth
5 57 67 1
Safety Safety
63 86 49 61
Combined
42 82 10 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
40 23 31 25
Price vs. Earnings (P/E)
78 1 1 1
Price vs. Book (P/B)
91 84 85 79
Dividend Yield
1 1 1 1
Value
76 41 44 18
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
6 10 6 1
Profit Growth
1 76 80 38
Capital Growth
42 28 75 4
Stock Returns
13 93 85 63
Growth
5 57 67 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
70 85 82 80
Refinancing
79 94 43 45
Liquidity
26 9 15 40
Safety Safety
63 86 49 61

Similar Stocks

Discover high‑ranked alternatives to OPKO Health and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Resideo Technologies

NYQ:REZI
Country: USA
Industry: Building Products
Size: Large
Full Stock Analysis

Pegasystems

NSQ:PEGA
Country: USA
Industry: Application Software
Size: Large
Full Stock Analysis

ACI

NSQ:ACIW
Country: USA
Industry: Application Software
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews